{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T08:36:57Z","timestamp":1784191017107,"version":"3.55.0"},"reference-count":27,"publisher":"American Academy of Pediatrics (AAP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,2,1]]},"abstract":"<jats:sec><jats:title>Objectives.<\/jats:title><jats:p>To determine the reactogenicity and immunogenicity of a fourth dose of 2 three-component acellular pertussis vaccines combined with diphtheria-tetanus-acellular pertussis (DTaP) when administered at preschool age to children primed in infancy with 3 doses of the same DTaP and who had received a diphtheria-tetanus (DT) dose at the age of 12 months.<\/jats:p><\/jats:sec><jats:sec><jats:title>Setting.<\/jats:title><jats:p>Local health units of 4 Italian regions.<\/jats:p><\/jats:sec><jats:sec><jats:title>Study Design.<\/jats:title><jats:p>Three thousand five hundred twenty-two children, who had been randomized in the first year of life to be immunized with a DTaP vaccine by either SmithKline Beecham or Chiron Biocine, were offered a booster of the same vaccine or, if refusing, a DT vaccine at the age of 5 to 6 years. Families of children were aware of the vaccine administered. The occurrence of adverse events was compared between the children who received a DTaP booster and those boosted with a DT only. Antibody titers to pertussis vaccine components (pertussis toxin, filamentous hemoagglutinin, and pertactin) were determined on 558 paired sera taken before and 30 days after the DTaP booster administration.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>Four episodes of temperature \u226539.5\u00b0C, 2 in each DTaP group, were recorded. Fever \u226538\u00b0C occurred infrequently in both DTaP and DT recipients (DTaP range: 2.5%\u20132.8%; DT range: 0%\u20134.8%), as did irritability (DTaP range: 10.1%\u201311.7%; DT range: 7.4%\u201312.6%). The frequency of local reactions was significantly higher for DTaP recipients (range: 44.0%\u201352.8%), with respect to DT recipients (range: 29.5%\u201344.4%). Extensive local reactions were observed in 1.2% of DTaP recipients and in .5% of DT recipients. Both DTaP vaccines induced high antibody titers against pertussis toxin, filamentous hemoagglutinin, and pertactin, with an increase of &amp;gt;10 times the prebooster geometric mean titers.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions.<\/jats:title><jats:p>A booster dose of DTaP at preschool age in children primed with the same acellular pertussis vaccine is safe and immunogenic. However, the frequency of local reactions is higher compared with that following primary immunization and with that following booster with DT only, and parents should be informed of the potential for these reactions to occur.<\/jats:p><\/jats:sec>","DOI":"10.1542\/peds.107.2.e25","type":"journal-article","created":{"date-parts":[[2004,8,13]],"date-time":"2004-08-13T23:55:51Z","timestamp":1092441351000},"page":"e25-e25","source":"Crossref","is-referenced-by-count":35,"title":["Reactogenicity and Immunogenicity at Preschool Age of a Booster Dose of Two Three-Component Diphtheria-Tetanus-Acellular Pertussis Vaccines in Children Primed in Infancy With Acellular Vaccines"],"prefix":"10.1542","volume":"107","author":[{"given":"Alberto Eugenio","family":"Tozzi","sequence":"first","affiliation":[{"name":"From the Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Anemona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Stat","sequence":"additional","affiliation":[{"name":"From the Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Stefanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Biol","sequence":"additional","affiliation":[{"name":"Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanita\u0300, Rome, Italy; and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Salmaso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Biol","sequence":"additional","affiliation":[{"name":"From the Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta Luisa Ciofi degli","family":"Atti","sequence":"additional","affiliation":[{"name":"From the Laboratory of Epidemiology and Biostatistics, Istituto Superiore di Sanita\u0300, Rome, Italy;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Mastrantonio","sequence":"additional","affiliation":[{"name":"Laboratory of Bacteriology and Medical Mycology, Istituto Superiore di Sanita\u0300, Rome, Italy; and the"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Giammanco","sequence":"additional","affiliation":[{"name":"Department of Hygiene and Microbiology, University of Palermo, Palermo, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the Progetto Pertosse Study Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2001,2,1]]},"reference":[{"key":"2021121009455351400_B1","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(88)91778-3","article-title":"Placebo-controlled trial of two acellular pertussis vaccines in Sweden\u2014protective efficacy and adverse events.","volume":"1","author":"Ad Hoc Group for the Study of Pertussis Vaccines","year":"1988","journal-title":"Lancet"},{"key":"2021121009455351400_B2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJM199602083340601","article-title":"A controlled trial of two acellular vaccines and one whole-cell vaccine against pertussis.","volume":"334","author":"Greco","year":"1996","journal-title":"N Engl J Med"},{"key":"2021121009455351400_B3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1056\/NEJM199602083340602","article-title":"A controlled trial of a two-component acellular, a five-component acellular, and a whole-cell pertussis vaccine.","volume":"334","author":"Gustafsson","year":"1995","journal-title":"N Engl J Med"},{"key":"2021121009455351400_B4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1056\/NEJM199510193331604","article-title":"A placebo-controlled trial of a pertussis-toxoid vaccine.","volume":"333","author":"Trollfors","year":"1995","journal-title":"N Engl J Med"},{"key":"2021121009455351400_B5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1996.03530250041024","article-title":"Efficacy of acellular pertussis vaccine in early childhood after household exposure.","volume":"275","author":"Schmitt","year":"1996","journal-title":"JAMA"},{"key":"2021121009455351400_B6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/S0264-410X(97)00224-7","article-title":"Catch-up primary vaccination with acellular pertussis vaccines in 3\u20134 year old children\u2014reactogenicity and serologic response.","volume":"16","author":"Warngard","year":"1998","journal-title":"Vaccine"},{"key":"2021121009455351400_B7","first-page":"843","article-title":"Infant immunization coverage in Italy: estimates by simultaneous EPI cluster surveys of regions.","volume":"77","author":"Salmaso","year":"1999","journal-title":"Bull WHO"},{"key":"2021121009455351400_B8"},{"key":"2021121009455351400_B9","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1016\/S0264-410X(98)00405-8","article-title":"Reactogenicity of a three-dose pertussis acellular vaccine catch-up in children 21\u201340 months of age.","volume":"17","author":"Ciofi degli Atti M, Anemona A, Tozzi AE, Stefanelli P, Giammanco A, Salmaso S","year":"1999","journal-title":"Vaccine"},{"key":"2021121009455351400_B10","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3109\/00365549609049068","article-title":"Antibody response and reactions to completion of a four-dose series with a two- or three-component acellular pertussis vaccine compared to whole cell pertussis vaccine.","volume":"28","author":"Pichichero","year":"1996","journal-title":"Scand J Infect Dis"},{"key":"2021121009455351400_B11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S0140-6736(97)04334-1","article-title":"Impact of anti-vaccine movements on pertussis control: the untold story.","volume":"351","author":"Gangarosa","year":"1998","journal-title":"Lancet"},{"key":"2021121009455351400_B12","first-page":"1","article-title":"Pertussis vaccination: use of acellular pertussis vaccines among infants and young children\u2014recommendations of the Advisory Committee on Immunization Practices (ACIP).","volume":"46","author":"Centers for Disease Control and Prevention","year":"1997","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"2021121009455351400_B13","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1016\/S0264-410X(98)00040-1","article-title":"Persistence of protection through 33 months of age provided by immunization in infancy with two three-component acellular pertussis vaccines: Stage II Working Group.","volume":"13","author":"Salmaso","year":"1998","journal-title":"Vaccine"},{"key":"2021121009455351400_B14"},{"key":"2021121009455351400_B15","first-page":"588","article-title":"Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines.","volume":"96","author":"Pichichero","year":"1995","journal-title":"Pediatrics"},{"key":"2021121009455351400_B16","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/S0264-410X(97)00163-1","article-title":"Predictors of adverse events after the administration of acellular and whole-cell diphtheria-tetanus-pertussis vaccines.","volume":"16","author":"Tozzi","year":"1998","journal-title":"Vaccine"},{"key":"2021121009455351400_B17","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.96.6.A48","article-title":"Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines.","volume":"96","author":"Meade","year":"1995","journal-title":"Pediatrics"},{"key":"2021121009455351400_B18"},{"key":"2021121009455351400_B19"},{"key":"2021121009455351400_B20","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1542\/peds.93.1.37","article-title":"Acellular and whole-cell pertussis vaccines as booster doses: a multicenter study.","volume":"93","author":"Englund","year":"1994","journal-title":"Pediatrics"},{"key":"2021121009455351400_B21","first-page":"62","article-title":"Adverse reactions and serologic response to a booster dose of acellular pertussis vaccine in children immunized with acellular or whole-cell vaccine as infants.","volume":"84","author":"Blennow","year":"1989","journal-title":"Pediatrics"},{"key":"2021121009455351400_B22","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.100.5.772","article-title":"A safety and immunogenicity comparison of 12 acellular pertussis vaccines and one whole-cell pertussis vaccine given as a fourth dose in 15- to 20-month-old children.","volume":"100","author":"Pichichero","year":"1997","journal-title":"Pediatrics"},{"key":"2021121009455351400_B23"},{"key":"2021121009455351400_B24","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0022-3476(98)70395-6","article-title":"Antibody responses and persistence in the two years after immunization with two acellular vaccines and one whole-cell vaccine against pertussis.","volume":"132","author":"Giuliano","year":"1998","journal-title":"J Pediatr"},{"key":"2021121009455351400_B25","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1016\/S0264-410X(98)00227-8","article-title":"Levels of antipertussis antibodies related to protection after household exposure to Bordetella pertussis.","volume":"16","author":"Storsaeter","year":"1998","journal-title":"Vaccine"},{"key":"2021121009455351400_B26","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1016\/S0264-410X(98)00226-6","article-title":"A search for serologic correlates of immunity to Bordetella pertussis cough illnesses.","volume":"16","author":"Cherry","year":"1998","journal-title":"Vaccine"},{"key":"2021121009455351400_B27","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1016\/S0264-410X(99)00065-1","article-title":"Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccines as a booster in 4\u20137-year-old children primed with diphtheria-tetanus-whole cell pertussis vaccine before 2 years of age.","volume":"17","author":"Dagan","year":"1999","journal-title":"Vaccine"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/2\/e25\/892230\/e25.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/107\/2\/e25\/892230\/e25.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,29]],"date-time":"2023-04-29T05:39:16Z","timestamp":1682746756000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/107\/2\/e25\/66221\/Reactogenicity-and-Immunogenicity-at-Preschool-Age"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,2,1]]},"references-count":27,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,2,1]]},"published-print":{"date-parts":[[2001,2,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.107.2.e25","relation":{},"ISSN":["1098-4275","0031-4005"],"issn-type":[{"value":"1098-4275","type":"electronic"},{"value":"0031-4005","type":"print"}],"subject":[],"published":{"date-parts":[[2001,2,1]]}}}